Home Cart 0 Sign in  
X

[ CAS No. 63136-60-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 63136-60-7
Chemical Structure| 63136-60-7
Chemical Structure| 63136-60-7
Structure of 63136-60-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 63136-60-7 ]

Related Doc. of [ 63136-60-7 ]

Alternatived Products of [ 63136-60-7 ]

Product Details of [ 63136-60-7 ]

CAS No. :63136-60-7 MDL No. :MFCD09264040
Formula : C10H8ClN Boiling Point : -
Linear Structure Formula :- InChI Key :PQBLNZUMJQLZAC-UHFFFAOYSA-N
M.W : 177.63 Pubchem ID :256888
Synonyms :

Calculated chemistry of [ 63136-60-7 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.1
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 51.72
TPSA : 12.89 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.13 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.21
Log Po/w (XLOGP3) : 3.18
Log Po/w (WLOGP) : 3.2
Log Po/w (MLOGP) : 2.71
Log Po/w (SILICOS-IT) : 3.56
Consensus Log Po/w : 2.97

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.56
Solubility : 0.0488 mg/ml ; 0.000275 mol/l
Class : Soluble
Log S (Ali) : -3.12
Solubility : 0.134 mg/ml ; 0.000755 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.7
Solubility : 0.00354 mg/ml ; 0.0000199 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.23

Safety of [ 63136-60-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 63136-60-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 63136-60-7 ]
  • Downstream synthetic route of [ 63136-60-7 ]

[ 63136-60-7 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 64965-46-4 ]
  • [ 63136-60-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 21, p. 6351 - 6363
[2] Journal of the American Chemical Society, 1946, vol. 68, p. 132
  • 2
  • [ 858488-66-1 ]
  • [ 63136-60-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 21, p. 6351 - 6363
[2] Journal of the American Chemical Society, 1946, vol. 68, p. 132
  • 3
  • [ 219949-95-8 ]
  • [ 63136-60-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 21, p. 6351 - 6363
[2] Journal of the American Chemical Society, 1946, vol. 68, p. 132
  • 4
  • [ 408532-32-1 ]
  • [ 63136-60-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 21, p. 6351 - 6363
[2] ACS Medicinal Chemistry Letters, 2018,
  • 5
  • [ 72553-74-3 ]
  • [ 63136-60-7 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2018,
  • 6
  • [ 52457-99-5 ]
  • [ 68-12-2 ]
  • [ 63136-60-7 ]
Reference: [1] Synthetic Communications, 1997, vol. 27, # 2, p. 337 - 343
  • 7
  • [ 136613-57-5 ]
  • [ 68-12-2 ]
  • [ 63136-60-7 ]
Reference: [1] Tetrahedron Letters, 1998, vol. 39, # 22, p. 3837 - 3840
[2] Tetrahedron, 1998, vol. 54, # 47, p. 14327 - 14340
  • 8
  • [ 1873-55-8 ]
  • [ 57876-69-4 ]
  • [ 63136-60-7 ]
Reference: [1] Heterocycles, 1991, vol. 32, # 8, p. 1579 - 1586
  • 9
  • [ 2591-86-8 ]
  • [ 136613-57-5 ]
  • [ 63136-60-7 ]
Reference: [1] Tetrahedron, 1998, vol. 54, # 47, p. 14327 - 14340
  • 10
  • [ 4394-85-8 ]
  • [ 136613-57-5 ]
  • [ 63136-60-7 ]
Reference: [1] Tetrahedron, 1998, vol. 54, # 47, p. 14327 - 14340
  • 11
  • [ 62-53-3 ]
  • [ 63136-60-7 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2018,
  • 12
  • [ 219949-95-8 ]
  • [ 63136-60-7 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2018,
  • 13
  • [ 858488-66-1 ]
  • [ 63136-60-7 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2018,
  • 14
  • [ 1196-28-7 ]
  • [ 68-12-2 ]
  • [ 63136-60-7 ]
Reference: [1] Synthetic Communications, 1997, vol. 27, # 2, p. 337 - 343
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 63136-60-7 ]

Chlorides

Chemical Structure| 21617-12-9

[ 21617-12-9 ]

4,8-Dichloroquinoline

Similarity: 0.87

Chemical Structure| 78941-93-2

[ 78941-93-2 ]

7-Chloro-8-methylquinoline

Similarity: 0.86

Chemical Structure| 1207-69-8

[ 1207-69-8 ]

9-Chloroacridine

Similarity: 0.86

Chemical Structure| 635-27-8

[ 635-27-8 ]

5-Chloroquinoline

Similarity: 0.86

Chemical Structure| 612-57-7

[ 612-57-7 ]

6-Chloroquinoline

Similarity: 0.85

Related Parent Nucleus of
[ 63136-60-7 ]

Quinolines

Chemical Structure| 21617-12-9

[ 21617-12-9 ]

4,8-Dichloroquinoline

Similarity: 0.87

Chemical Structure| 78941-93-2

[ 78941-93-2 ]

7-Chloro-8-methylquinoline

Similarity: 0.86

Chemical Structure| 635-27-8

[ 635-27-8 ]

5-Chloroquinoline

Similarity: 0.86

Chemical Structure| 612-57-7

[ 612-57-7 ]

6-Chloroquinoline

Similarity: 0.85

Chemical Structure| 58401-43-7

[ 58401-43-7 ]

4-Chloroquinolin-3-amine

Similarity: 0.85